Literature DB >> 3155536

Species specificity of recognition by the alternative pathway of complement.

R D Horstmann, M K Pangburn, H J Müller-Eberhard.   

Abstract

The recognition function of the alternative complement pathway was studied with isolated human and rabbit components. Zymosan and homologous and heterologous erythrocytes were used as representative activators or nonactivators. The binding affinity of Factor B and Factor H for particle-bound C3b was measured. In both species, the average affinity of Factor H for bound C3b on homologous cells (nonactivators) was eight to 10 times higher than on zymosan particles (activators). The interaction between Factor H and C3b on rabbit erythrocytes was species-specific: rabbit Factor H bound strongly to rabbit C3b on rabbit erythrocytes and also on human erythrocytes, which are nonactivators for the rabbit alternative pathway. Human Factor H bound strongly to human C3b on human erythrocytes but seven times weaker on rabbit erythrocytes, which are activators of the human alternative pathway. No substantial differences were found in the binding of Factor B to bound C3b regardless of the nature of the particle to which C3b was bound. The results indicate that in the two species studied, the molecular mechanism of recognition is analogous and that recognition is species-specific.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155536

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.

Authors:  V Koistinen
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

Review 2.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.

Authors:  Marcellene A Gates; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.

Authors:  V Koistinen
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

5.  Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Hanna Jarva; Sanjay Ram
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

6.  Identification of Lyme borreliae proteins promoting vertebrate host blood-specific spirochete survival in Ixodes scapularis nymphs using artificial feeding chambers.

Authors:  Thomas Hart; Xiuli Yang; Utpal Pal; Yi-Pin Lin
Journal:  Ticks Tick Borne Dis       Date:  2018-04-04       Impact factor: 3.744

7.  Binding of Cryptococcus neoformans to heterologously expressed human complement receptors.

Authors:  S M Levitz; A Tabuni; T R Kozel; R S MacGill; R R Ingalls; D T Golenbock
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

8.  Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.

Authors:  Thomas R Kozel; Randall S MacGill; Ann Percival; Qing Zhou
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.

Authors:  A K Sharma; M K Pangburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.